DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,448,744 | +0.0% | 55,571 | -0.5% | 0.22% | +1.9% |
| Q2 2023 | $55,432,297 | +794.7% | 55,863 | +795.4% | 0.22% | +795.8% |
| Q1 2023 | $6,195,327 | +386.4% | 6,239 | +30.0% | 0.02% | -42.9% |
| Q4 2022 | $1,273,750 | -0.7% | 4,799 | -3.4% | 0.04% | -8.7% |
| Q3 2022 | $1,283,000 | -15.3% | 4,969 | -16.8% | 0.05% | -9.8% |
| Q2 2022 | $1,515,000 | +2.6% | 5,975 | +18.7% | 0.05% | +27.5% |
| Q1 2022 | $1,476,000 | -44.5% | 5,032 | -40.2% | 0.04% | -42.0% |
| Q4 2021 | $2,658,000 | -42.1% | 8,417 | -44.2% | 0.07% | -46.1% |
| Q3 2021 | $4,589,000 | +17.3% | 15,075 | +3.4% | 0.13% | +14.3% |
| Q2 2021 | $3,911,000 | +25.0% | 14,575 | +4.9% | 0.11% | +13.1% |
| Q1 2021 | $3,128,000 | +7.8% | 13,894 | +6.3% | 0.10% | 0.0% |
| Q4 2020 | $2,902,000 | -6.8% | 13,069 | -9.6% | 0.10% | -19.5% |
| Q3 2020 | $3,113,000 | +36.5% | 14,455 | +12.1% | 0.12% | +9.8% |
| Q2 2020 | $2,280,000 | +64.3% | 12,899 | +28.7% | 0.11% | +21.7% |
| Q1 2020 | $1,388,000 | -7.9% | 10,026 | +2.1% | 0.09% | +4.5% |
| Q4 2019 | $1,507,000 | – | 9,815 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |